Amdipharm Mercury Co., Ltd. - AMCo.

No 1 Croydon, 12-16 Addiscombe Road,
Croydon, CR0 0XT
United Kingdom,
+44 (0) 208 588 9100
www.amcolimited.com

Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.4/yr) # 1 1 - 1 - - 3
vol $77M $77M
Sell (0.0/yr) # - - - - - - 0
  3

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Focus Pharmaceuticals Ltd.
$77M (2010-10-01)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Amdipharm Mercury - AMCo. was acquired by Concordia Healthcare on September 08, 2015.

Amdipharm Mercury - AMCo. has acquired 3 companies of its own, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms.

Amdipharm Mercury - AMCo.’s largest acquisition to date was in 2010, when it acquired Focus Pharmaceuticals for $77M. Amdipharm Mercury - AMCo. has acquired in 3 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 415 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 3 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 25 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Amdipharm Mercury - AMCo.’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.